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     Aldolase C as a glycolytic enzyme is associated with cellular structure at developmental stages of 
all cells, and this is particularly evident during the early stages of morphogenesis. It seems that 
expression of aldolase C can be regulated by the rate of differentiation that depends on the level of 
transcription or mRNA stability. There are several techniques to detect gene expression, here 
proteomics was used for determining expression of aldolase C (as a differentiation factor) in several 
cell types and basal cell carcinoma (BCC) tissue. The human astrocytes were differentiated from 
mesanchymal stem cells, fibroblast cells were cultured as primary cell culture and BCC tissue was 
taken from the patient. The fibroblast cells divided into two groups including sham and exposed 
groups. The exposed cells are them that were exposed to continue Extremely Low-Frequency 
Electromagnetic Fields (ELF-EMF).   The analysis of 2DE gels, showed different expression of 
aldolase C in mentioned cells. The findings indicate that the amount of aldolase C expression 
decreases as differentiation process develops.  
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INTRODUCTION 
     The glycolysis pathway is undoubtedly one 
of the most centrally situated pathways in 
metabolism. Glycolysis enzymes are associated 
with cellular structure at all developmental 
stages, and this is particularly evident during 
the early stages of morphogenesis. Certain 
enzymes bind more readily to cellular structure 
(such as phosphofructokinase, aldolase, 
glyceraldehyde phosphate dehydrogenase, 
pyruvate kinase and dehydrogenase) than the 
other glycolytic enzymes and much of this 
binding is associated with actin-containing 
filament [1]. Aldolase C, found on human 
chromosome 17, has kinetic properties that are 
intermediate between those of A and B isoforms 
[2]. Findings have indicated that Zebrin II 
which is an 3×103 Mr antigen, is aldolase C and 
its expression is regulated at the level of 
transcription or mRNA staibility [3]. It seems 
that aldolase C gene is almost transcribed in all 
cell types. Studies using isozyme-specific 
antibodies report its location in gray matter 
astrocytes and cells of the pia matter [2, 4]. 
Aldolase C mRNA expression is highest in the 
cerebellum [5]. Aldolase C increases during the 
development of mammalian fetal brain, and is 
Expressed at high levels in adult brain [6,7]. 
Although very low level of aldolase C has been 
found in some non nervous tissues, its gene is 
transcribed mostly in neurons. 
Astrocyte is an absolute differentiated cell. 
Stem cell is mesenchymal cell with high 
capacity to differentiate into any mature cell 
types. Fibroblast seems to be the least 
specialized cells in the connective-tissue family. 
One of the underlying principles of specific 
types of cells in multicellular organisms is 
that the functions and properties of each cell 
type are determined by the proteins it 
contains. The procedure that is used to 
analyze change in expression of many 
proteins in a cell is proteomics. In the 
proteomics, the proteins are separated and can 
then be identified by mass spectrometry. 
Today, this technique is used in many 
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researches in order to identify gene expression 
in specific types of cells in multicultural 
organism [9, 10]. Here, the amount of 
expression of aldolase C in the normal human 
stem cell, fibroblast, exposed fibroblast cell 
(the cell that is exposed to continues 
Extremely Low-Frequency Electromagnetic 
Fields (ELF-EMF)) and astrocytes were 
investigated by proteomics.  For getting more 
illustration, these results were compared to an 
abnormal condition like as Basal cell 
carcinoma (BCC) tissue. 
 
MATERIALS AND METHODS 
 Sample preparation 
    Human skin fibroblasts were prepared from 
foreskin tissue  and grown to 80% confluence 
in Dulbecco’s modified Eagle medium 
(DMEM; 4.5 g/liter glucose) supplemented 
with 10% fetal bovine serum, 0.58 g/liter L-
glutamine, 100 units/ml penicillin, and 100 
µg/ml streptomycin at 37 °C under isobaric 
conditions (5% CO2, 95% air) in humidified 
atmosphere.  
To compare the effect of environmental stress 
condition on gene expression, one group of 
fibroblast cells were exposed to continues 
Extremely Low-Frequency Electromagnetic 
Fields (ELF-EMF) (3Hz, sinusoidal, 3h and 
4mT). Then media was removed, cells were 
washed three times with phosphate-buffered 
saline and lysed by adding lysis buffer (7 M 
urea, 2 M thiourea, and 1% Triton X-100) and 
prepared for 2DE process [11]. 
It is important to compare between normal 
and cancer cell to find out the differential rate 
of cellular protein contain so, used Basal cell 
carcinoma  (BCC). BCC tissues sample was 
taken from patient. Fresh tissue samples of 
skin were snap frozen and kept in liquid 
nitrogen until use. Tissue samples were 
powdered by microdismembrator at maximum 
speed for 60 seconds under liquid nitrogen 
conditions. Each powdered tissue sample was 
added to an appropriate amount of lysis buffer 
containing 10 mM Tris-HCl pH=7.5, 1 mM 
MgCl2, 1 mM EGTA, 0.1 mM 
Phenylmethylsulfonyl fluoride (PMSF), 5 mM 
betamercapto ethanol, 0.5% CHAPS and 10% 
glycerol. After 30 minutes incubation on ice, 
the lysate was centrifuged at 16000g for 30 
minutes at 4°C. Protein concentration of all 
samples was estimated using a Bradford based 
 microassay[12]. 
 
Isolation of mesenchymal stem cells 
(MSCs) 
 Briefly, each aspirate was diluted 1:1 with 
DMEM and layered over 1:1 Ficoll (Ficoll- 
Paque Plus; GE Healthcare Bio-Sciences, 
Baie-d’Urfé, QC). After centrifugation at 
900×g for 30 min, the mononuclear cell layer 
was removed from the interface, washed with 
DMEM, and resuspended in DMEM 
supplemented with 10% fetal bovine serum 
(Hyclone, Logan, UT), 100 units/ml 
penicillin, 100 µg/ml streptomycin, and 2 mm 
l-glutamine. The cells were plated in 20 ml of 
medium in a 176-cm2-culture dish and 
incubated at 37 °C in a 5% CO2 humidified 
atmosphere. After 72 h, non-adherent cells 
were discarded and the adherent cells were 
thoroughly washed twice with DMEM. 
Thereafter, the cells were expanded [13]. 
 
Immunophenotyping of MSCs by flow 
cytometry 
 Expanded MSCs were detached from the 
culture flask by the use of PBS (pH 7.4) 
containing trypsin (0.05%) and EDTA 
(0.02%), washed once with DMEM and once 
with filtrated PBS. Cells were next suspended 
at a concentration of 1 × 106 cells in 50 µl 
PBS and incubated for 45 min at 4 °C in the 
dark with FITC or PE-conjugated antibodies 
as follows: anti-CD29-PE, anti-CD54-PE, 
anti-CD44-FITC, anti-CD45-FITC, anti-
CD73-FITC, anti-CD166-FITC, anti-CD105-
PE, anti-CD34-FITC, and anti-CD31-FITC. In 
parallel, cells were incubated with an 
irrelevant antibody (anti-Aspergillus niger 
glucose oxidase, Dako) as a negative isotype 
control to exclude non-specifically labelled 
cells from the calculation. Upon completion 
of the incubation time, cells were washed 
twice with PBS supplemented with 2% BSA 
and fixed with 1% paraformaldehyde solution 
in PBS. Analysis was next performed using a 
flow cytometer (FACsort, BD, USA). Before 
each test, the percentage of viability that was 
more than 95% was measured with trypan-
blue staining and dead cells were counted 
with a neobar slide. 
 
Dِifferentiation of MSCs into Neural like 
cells: The adult human mesenchymal stem 
cells used, were frozen twice and passaged a 
total of seven times. 2 × 105 mesenchymal 
stem cells were thawed and suspended in the 
neurosphere-inducing media in 35 mm dishes. 
The neurosphere media consisted of 
Neurobasal A media (GIBCO BRL), B27 
proliferation/cell expansion supplement, 1% 
antibiotic/antimycotic, 20 ng/ml epidermal 
growth factor (EGF) and 20 ng/ml basic 
fibroblastic growth factor (bFGF) (Sigma). 
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The floating neurospheres that formed 
received additional EGF and bFGF every 3–5 
days for 15 days. Ten µM of forskolin and 
0.1 mM of isobutylmethylxanothine (IBMX), 
a phosphodiesterase inhibitor, were added to 
the preliminary neurosphere media to increase 
cyclic AMP in later experiments. An increase 
in intracellular cAMP has been shown to 
promote neuronal signaling mechanisms [14]. 
 
Immunocytochemistry 
 Immunocytochemical staining was performed 
to examine the NF expression in MSCs at 
24 h post neuron induction. The cultures were 
washed with D-PBS and fixed with 4% 
paraformaldehyde at 37°C for 10 min. The 
cells were then permeabilized with 1% Triton 
at room temperature for 10 min. Following 2 
rinses with 0.5 mg/ml sodium borohydride, 
the cells were incubated with 5% normal goat 
serum and then 6% BSA, each at room 
temperature for 30 min, to block non-specific 
antibody binding. The cells were subsequently 
incubated with a rabbit anti-human NSE 
antibody at 37°C for 1 h, and a goat anti-
rabbit IgG antibody conjugated with Alexa 
Fluor 488 at 37°C for 40 min. In other 
experiments, cells were incubated for 60 min 
at room temperature with monoclonal 
antibodies against neuron specific enolase 
(NSE; 1:20, Cymbus Biotechnology). 
Subsequently, slides were rinsed three times 
in PBS-Triton, incubated for 30 min with 
biotinylated antimouse IgG (1:200, Vector) 
and rinsed and incubated with horseradish 
peroxidase conjugated avidin D (1:800, 
Vector), followed by 10 min incubation with 
DAB tablet sets (SIGMA FAST). Negative 
controls were routinely performed for each 
experiment, incubating the samples with non-
immune serum and with biotinylated anti-
mouse IgG. Six different experiments were 
performed for each marker. 
 
Two dimensional SDS-PAGE 
 Briefly, human astrocyte on 25mm2 dishes 
was washed three times in PBS. 300µl lysis 
buffer (7M urea, 2M thiourea, 4%CHAPS, 
0.2-0.3%DTT,1-2% ampholine 3-10) was 
added to cell culture and shaking was done at 
room temperature for 1 h. The lysate was 
centrifuged at 10000 g for 10 min at room 
temperature. The supernatant was used for 
protein assay according to Bradford protein 
assay (15) and subsequently was kept at -
20˚C. Linear pH 3-10 Immobilized Dry Strip 
(17 cm) were rehydrated overnight at 20˚C in 
rehydration buffer( 8.5M urea,2% CHAPS, 
40mM DTT, 0.1% ampholin, 0.001% 
bromophenol blue). Sample (400µg) was 
applied during rehydration. The first 
dimension of 2D electrophoresis was 
performed on the PROTEAN IEF Cell system 
(Bio-Rad). Next, gels were equilibrated for 15 
min in equilibration buffer I (6M urea, 2% 
SDS, 0.375 M Tris Hcl pH8.8, 20% glycerol, 
130mM DTT). A 12% SDS-Polyacrylamide 
slab gel was used for second dimension gel 
electrophoresis. Equilibrated IPG strips were 
placed on the surface of second dimension 
gels and were then sealed with 0.5% agarose 
in SDS electrophoresis buffer (25mM Tris 
base, 192mM glycine, 0.1%SDS) and were 
run vertically [16]. 
 
2DE gel staining 
  After electrophoresis, the gels were stained 
with silver stain [17] Coomassie Brilliant 
Blue staining [18]. 
 
Bioinformatics analysis 
 2DE gels were scanned and gels were 
analyzed by Bionumeric and fliker soft wares 
to compare the spots in one statement in gels 
and get the density of same spot in each of 
gel. Then, the spots were compared to data 
banks to detect the spots in one statement in 




 Stained protein spot containing the interested 
protein was destained thoroughly with 1% 
H2O2 (typically 1 min) and lyophilized to 
dryness [19]. stain removal using H2O2 was 
performed to enhance peptide adsorption by 
matrix-assisted laser desorption/ionization 
time-of- flight mass spectrometry (MALDI) 
[20]. The dehydrated gel bands were hydrated 
with 15 µg/l (Promega, Madison, WI) of 
porcine trypsin in 25 mmol/L NH4HCO3, 
pH8.2 on ice for 45 min. Excess trypsin was 
removed; gel bands were covered with 25 
mmol/l NH4HCO3, pH8.2 and incubated at 
37°C overnight. Tryptic peptides were 
extracted from the gel bands with 70% 
acetonitrile and 0.1% trifl uoroacetic acid. 
Sample was desalted with C18 Zip Tips 
(Millipore, Bedford, MA) as 
permanufacturer's protocols. 0.5 µl of sample 
was co-crystallized with 0.5 µl of α-cyano-4-
hydroxycinnamic acid in 50% acetonitrile, 1% 
trifluoroacetic acid and spotted directly on a 
stainless steel MALDI target plate. Mass 
spectra were acquired using a MALDI-
TOF/TOF mass spectrometer (Voyager 4700, 
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Applied Biosystems, Foster City, CA). 
MALDI-TOF/TOF spectra were internally 
calibrated (< 20 ppm) using trypsin autolysis 
products. Post-acquisition baseline correction 
and smoothing was carried out using software 
provided with the TOF/TOF instrument. 
Spectra were submitted to Mascot 




     Since fibroblast cell is a least 
differentiated cell and is near to stem cell and 
astrocyte is a differentiated cell, the 
comparison of their proteome will show 
pathway of differentiation. Figure1 shows the 
human mesenchymal stem cells (MSCs), 
human fibroblast and astrocyte cell NSE 









Figure 1. a) mesenchymal stem cells-NSE staining 
(neuron specific enolase), b) human fibroblast and c) 
astrocyte. 
 
2DE in combination with mass spectrometry 
and bioinformatics analysis were used for 
protein identification. The first step in 
proteomics study is protein extraction and the 
second is protein separation. The proteomes of 
stem cell, fibroblast, astrocyte, exposed 
fibroblast and BCC tissue were provided and 
analyzed by bionameric and flicker software. 
As it is shown in figure 2, the similar part of gel 
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Figure 2. Two dimensional images of a) mesenchymal 
stem cells, b) human fibroblast, c) astrocyte, d) exposed 
fibroblast and e) BCC tissue. The selected spot of every 
gel refers to aldolase c protein. 
 
Bionumerics software is a suitable tool for 
detection of density of the spots compared to 
the similar ones on the other gels. By using 
Bionumerics software, density of the 
mentioned spot in all gels was determined and 
were tabulated in table1. Flicker analysis 
indicated that the mentioned spot correspond 
to the aldolase C. For confirming the flicker 
analysis, mass spectrometry 
(MALDI/TOF/TOF / MASCOT) was used. 
The finding of mass spectrometry (Mascot 
Search Results) indicates that the desired 
protein is aldolase C. 
 
Table 1.  Aldolase C expression of different cells was 
determined by using Bionamerics software 
   
Type of cell max  
volume 
volume 
Stem cell 78 ± 4.5 2089 ± 18.7 
Fibroblast 32±  5.6 1177 ± 13.6 








     Class I aldolases include three tissue-
specific isoenzymes in vertebrate tissues: 
aldolase A predominates in skeletal muscle 
and red blood cells, aldolase B in liver, 
kidney, and small intestine, and aldolase C in 
neuronal tissues and smooth muscle [21]. It 
was also identified aldolase A in human skin 
fibroblasts [29]. As it is depicted in the figures 
1 stem cell, fibroblast and astrocyte have 
different morphology. Astrocyte is an 
absolute differentiated cell while stem cell is 
undifferentiated cell with high capacity for 
differentiation. Fibroblast seems to be the 
least specialized cells in the connective-tissue 
family [9, 30]. The actions and properties of 
each cell type in multicellular organisms are 
determined by the proteins it contains. Many 
of the proteins within cells are enzymes, other 
proteins allow cells to move and do work, 
maintain internal cell rigidity, and transport 
molecules across membranes. In the figure 2, 
the similar and  desired part of 2DE gel 
correspond to the stem cell, fibroblast cells, 
astrocyte, exposed fibroblast and basal cell 
carcinoma tissue are shown. By using 
Bionamerics software, the amounts of 
aldolase C for all cell lines and also BCC 
tissue that are shown in table 1 indicate that a) 
aldolase C expression was suppressed 
completely in exposed fibroblast and also 
BCC tissue, b) amount of aldolase C 
expression reduced from stem cell, fibroblast 
and astrocyte, respectively and c) it is 
interesting that radiation as an environmental 
stress (differentiated motor 
factor) suppresses aldolase C expression. 
However, the radiation type is none ionized. 
 Aldolase serves as scaffolding protein linking 
insulin-responsive glucose transporter 
(GluT4) and hence GluT vesicle to the actin 
cytoskeleton [31]. Glycolytic enzyme can 
modulate cellular life span. Early passage 
MEFs have high glycolytic activity, which 
declines during replicative senescence and is 
reestablished during spontaneous 
immortalization. Inhibition of glycolytic 
enzymes can induce senescence.  Like 
neurofilament, aldolase A and C are expressed 
early in embryonic development, are up 
regulated during postnatal life [7]. The 
molecular mechanisms of the brain-specific 
expression of this gene are still poorly 
understood. A complete set of the regulating 
elements required for CNS-specific 
expression of the aldolase C gene is present 
between -6 Kb and +7 Kb of the gene [32].  
     Finally, it can be concluded that amount of 
aldolase C expression is a suitable biomarker 
for differentiation progress in the cell lines, so 
its expression decreases as cell differentiation 
develops. 
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